Change of cerebral regional oxygen saturation using near-infrared spectroscopy at spinal anesthesia and at dexmedetomidine or propofol administration

Change of cerebral regional oxygen saturation using near-infrared spectroscopy at spinal anesthesia and at dexmedetomidine or propofol administration - Change of cerebral regional oxygen saturation at spinal anesthesia and at dexmedetomidine or propofol administration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026225

Enrollment

Registered

2017-02-20

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder tumor

Interventions

Dexmedetomidine Propofol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo elective transurethral resection of bladder tumor under spinal anesthesia combined with sedation using dexmedetomidine or propofol.

Exclusion criteria

Exclusion criteria: Patients with cerebral diseases.

Design outcomes

Primary

Measure	Time frame
Cerebral regional tissue oxygen saturation values during dexmedetonidine sedation or propofol sedation under spinal anesthesia.	—

Countries

Japan

Contacts

Public ContactTadahiko Ishiyama

University of Yamanashi, Faculty of Medicine, University of Yamanashi Hospital Surgical Center

ishiyama@yamanashi.ac.jp055-273-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026